Effective July 17, 2013, the Manitoba Drug Benefits Formulary will include Aclasta® (zoledronic acid) for Pharmacare reimbursement upon an individual prescriber/patient request basis.
Because calcium can interfere with the absorption of other drugs, do not take other medications within 1-2 hours of taking calcium, or as indicated on the product monograph of the other medication. Tell your doctor about all prescription and non-prescription drugs you may be using. Do not start or stop any medicine without doctor or pharmacist approval. Interactions may occur with the following...
Dr. David Goltzman is the 2012 Lindy Fraser Memorial Award recipient! Osteoporosis Canada established this award in 1993. This prestigious award recognizes individuals who have done exemplary research and have helped to increase the knowledge about osteoporosis. The recipient is nominated by members of our Scientific Advisory Council.
Osteoporosis is a disease that causes bones to become thin and weak, leading to an increased risk of a fragility fracture. The most common sites for broken bones caused by osteoporosis are the wrist, hip, shoulder and spine. Osteoporosis Canada has recently launched the Stand Tall Canada campaign to raise awareness of the fact that height loss can be an indicator of a spine fracture and to encourage people who have lost height to see their doctor.
Dr. Angela Cheung was the recipient of the 2012 Dr. David Sackett Senior Investigator Award from the Canadian Society of Internal Medicine. The award recognizes excellence in research by a senior Canadian general internist. Dr. Cheung gave her keynote address on "The Art and Science of Clinical Research" at the recent CSIM annual meeting on October 19, 2012 in Quebec City.
Dr Angela Cheung is the incoming chair of Osteoporosis Canada’s Scientific Advisory Council. Angela joined the SAC in 2001 and has sat on numerous SAC committees over the years. Angela was the recipient of the 2012 OC Lindy Fraser Award. She was instrumental in the development of the 2010 guidelines and their promotion and dissemination.
The 2012 Canadian Society of Endocrinology and Metabolism Young Investigator Award is awarded each year to an individual who has been a faculty member at a Canadian university between 5 and 10 years and has demonstrated excellence as an independent investigator.
Osteoporosis Canada is proud to report that 28 individuals, representing various aspects of the organization, are recipients of the Queen Elizabeth II Diamond Jubilee Medal.
Thanks to a partnership between Southlake Regional Health Centre in Newmarket and the Ontario Telemedicine Network, this first-of-its-kind initiative includes lectures and demonstrations provided by rheumatologists, occupational therapists, physiotherapists, kinesiologists, pharmacists and dietitians and is available across the province of Ontario.
To update the 1993 burden of illness of osteoporosis in Canada, administrative and community data were used to calculate the 2010 costs of osteoporosis at $2.3 billion in Canada or 1.3% of Canada’s healthcare expenditures. Prevention of fractures in high-risk individuals is key to decrease the financial burden of osteoporosis. Read more
Bridge Across Canada is an exciting and innovative event that invites bridge players to pursue their passion while raising funds for Osteoporosis Canada. Endorsed by the Canadian Bridge Federation, Bridge Across Canada (BAC) participants meet weekly to enjoy a weekly bridge game, garner fundraising tips from experts and gain further insight into Osteoporosis Canada's campaign to Bridge the Care Gap in Canada.
It is with much sadness that we share with you the passing of Dr. Colin Webber on September 4, 2012. Dr. Webber was a prominent professor, researcher and mentor at McMaster University and served as an SAC member for many years.
Join Osteoporosis Canada on June 17, 2012 as it celebrates 30 years of dedicated service to those with or at risk of osteoporosis. Established in 1982, the first organization in the world committed solely to bone health. Osteoporosis Canada remains the only organization in Canada with this primary focus.
On May 25, 2012 Sun Life Financial announced a donation of $ 103,232 to the Fracture Navigator Program, led by Dr. Diane Theriault at the Dartmouth General Hospital. For patients with osteoporosis in the community, this program will help reduce future medical complications, including repeat fractures, through early diagnosis and appropriate treatment.
The Canadian Osteoporosis Patient Network (COPN) achieved a significant milestone in its efforts to reach out to Canadians affected by osteoporosis with the recent signing of its 5000th member, Ottawa resident Judy Reaves.
Osteoporosis Canada hosted its Inaugural FOCUS Forum on November 12-14, 2011. The Focus Forum was attended by a multi-disciplinary group of health professionals and Osteoporosis Canada (OC) volunteers from across Canada.
Amgen Canada today announced that Health Canada has approved Prolia™ (denosumab) as another treatment choice for osteoporosis patients.
Health Canada has approved a 150mg dosing option for Actonel ® (risedronate sodium tablets), making it the only once-a-month dosing option in Canada for the treatment of postmenopausal osteoporosis.
A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition known as Osteonecrosis of the Jaw (ONJ).